| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.052 | 0.4 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |